| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 75551* | 2016 |
| Rivaroxaban versus warfarin in nonvalvular atrial fibrillation MR Patel, KW Mahaffey, J Garg, G Pan, DE Singer, W Hacke, G Breithardt, ... New England Journal of Medicine 365 (10), 883-891, 2011 | 12285 | 2011 |
| Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations RW Troughton, CM Frampton, TG Yandle, EA Espine, MG Nicholls, ... The Lancet 355 (9210), 1126-1130, 2000 | 2152 | 2000 |
| Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised … Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ... The Lancet 372 (9644), 1174-1183, 2008 | 1258 | 2008 |
| Plasma N-terminal pro–brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction AM Richards, MG Nicholls, TG Yandle, C Frampton, EA Espiner, ... Circulation 97 (19), 1921-1929, 1998 | 1055 | 1998 |
| The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) European heart journal 33 (14), 1750-1757, 2012 | 956 | 2012 |
| Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment PJ Hunt, AM Richards, MG Nicholls, TG Yandle, RN Doughty, EA Espiner Clinical endocrinology 47 (3), 287-296, 1997 | 826 | 1997 |
| Plasma brain natriuretic peptide in assessment of acute dyspnoea M Davis, EA Espiner, T Yandle, G Richards, I Town, A Neill, C Drennan, ... The Lancet 343 (8895), 440-444, 1994 | 782 | 1994 |
| B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction AM Richards, MG Nicholls, EA Espiner, JG Lainchbury, RW Troughton, ... Circulation 107 (22), 2786-2792, 2003 | 774 | 2003 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, HJC McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 602 | 2021 |
| Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath JG Lainchbury, E Campbell, CM Frampton, TG Yandle, MG Nicholls, ... Journal of the American College of Cardiology 42 (4), 728-735, 2003 | 542 | 2003 |
| Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers AM Richards, H Ikram, TG Yandle, MG Nicholls, MWI Webster, EA Espiner The Lancet 325 (8428), 545-549, 1985 | 516 | 1985 |
| 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial M Than, L Cullen, S Aldous, WA Parsonage, CM Reid, J Greenslade, ... Journal of the American College of Cardiology 59 (23), 2091-2098, 2012 | 503 | 2012 |
| N-terminal pro–B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP–Assisted Treatment To Lessen Serial Cardiac … JG Lainchbury, RW Troughton, KM Strangman, CM Frampton, A Pilbrow, ... Journal of the American College of Cardiology 55 (1), 53-60, 2009 | 471 | 2009 |
| Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure J Ritzema, R Troughton, I Melton, I Crozier, R Doughty, H Krum, A Walton, ... Circulation 121 (9), 1086-1095, 2010 | 468* | 2010 |
| A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study M Than, L Cullen, CM Reid, SH Lim, S Aldous, MW Ardagh, WF Peacock, ... The Lancet 377 (9771), 1077-1084, 2011 | 451 | 2011 |
| Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction TJ Mocatta, AP Pilbrow, VA Cameron, R Senthilmohan, CM Frampton, ... Journal of the American College of Cardiology 49 (20), 1993-2000, 2007 | 446 | 2007 |
| Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis IL Gerber, RAH Stewart, ME Legget, TM West, RL French, TM Sutton, ... Circulation 107 (14), 1884-1890, 2003 | 441 | 2003 |
| Biology of the natriuretic peptides A Martinez-Rumayor, AM Richards, JC Burnett, JL Januzzi Jr The American journal of cardiology 101 (3), S3-S8, 2008 | 435 | 2008 |
| Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction AM Richards, R Doughty, MG Nicholls, S MacMahon, N Sharpe, J Murphy, ... Journal of the American College of Cardiology 37 (7), 1781-1787, 2001 | 429 | 2001 |
